menu
    • menu

    Find Methotrexate manufacturers, exporters & distributors on PharmaCompass

    Fermion Methotrexate

    Virtual Booth

    Contact Supplier

    Rochem Methotrexate

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Pfanstiehl Methotrexate

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    45

    API Suppliers

    API Suppliers

    21

    USDMF

    US DMFs Filed

    7

    CEP/COS

    CEP/COS Certifications

    4

    JDMF

    JDMFs Filed

    3

    EU WC

    EU WC

    0

    KDMF

    KDMF

    10

    NDC API

    NDC API

    0

    VMF

    NDC API

    27

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 3,826

    MARKET PLACE

    19

    API

    23

    FDF

    7INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    653

    FDF Dossiers

    FDF Dossiers

    128

    FDA Orange Book

    FDA (Orange Book)

    358

    Europe

    Europe

    46

    Canada

    Canada

    55

    Australia

    Australia

    12

    South Africa

    South Africa

    54

    Listed Dossiers

    Listed Dossiers

    56DRUGS IN DEVELOPMENT

    FDF DossiersDRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    6

    EDQM

    5

    USP

    4

    JP

    6

    Others

    PATENTS & EXCLUSIVITIES

    136

    US Patents

    2

    US Exclusivities

    0

    Health Canada Patents

    DIGITAL CONTENT

    3

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    122

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    28,800,836

    Annual Reports

    NA

    Finished Drug Prices

    Listed Dossiers

    229 RELATED EXCIPIENT COMPANIES

    367EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 59-05-2, Amethopterin, Rheumatrex, Methylaminopterin, Abitrexate, Trexall
    Molecular Formula
    C20H22N8O5
    Molecular Weight
    454.4  g/mol
    InChI Key
    FBOZXECLQNJBKD-ZDUSSCGKSA-N
    FDA UNII
    YL5FZ2Y5U1
    Methotrexate
    An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA.
    Methotrexate is a Folate Analog Metabolic Inhibitor. The mechanism of action of methotrexate is as a Folic Acid Metabolism Inhibitor.
    1 2D Structure

    Methotrexate

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid
    2.1.2 InChI
    InChI=1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1
    2.1.3 InChI Key
    FBOZXECLQNJBKD-ZDUSSCGKSA-N
    2.1.4 Canonical SMILES
    CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O
    2.1.5 Isomeric SMILES
    CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
    2.2 Other Identifiers
    2.2.1 UNII
    YL5FZ2Y5U1
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Amethopterin

    2. Dicesium Salt Methotrexate

    3. Hydrate, Methotrexate

    4. Methotrexate Hydrate

    5. Methotrexate Sodium

    6. Methotrexate, (d)-isomer

    7. Methotrexate, (dl)-isomer

    8. Methotrexate, Dicesium Salt

    9. Methotrexate, Disodium Salt

    10. Methotrexate, Sodium Salt

    11. Mexate

    12. Sodium, Methotrexate

    2.3.2 Depositor-Supplied Synonyms

    1. 59-05-2

    2. Amethopterin

    3. Rheumatrex

    4. Methylaminopterin

    5. Abitrexate

    6. Trexall

    7. Mexate

    8. Metatrexan

    9. Hdmtx

    10. Methylaminopterinum

    11. Mtx

    12. (s)-2-(4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic Acid

    13. Methotrexatum

    14. Rasuvo

    15. 4-amino-10-methylfolic Acid

    16. Metotrexato

    17. Maxtrex

    18. Nsc-740

    19. Mexate-aq

    20. N-bismethylpteroylglutamic Acid

    21. Folex

    22. Nci-c04671

    23. Cl-14377

    24. Antifolan

    25. Methotrexate Lpf

    26. Xatmep

    27. 133073-73-1

    28. Amethopterine

    29. Farmitrexat

    30. Emt 25,299

    31. L-amethopterin

    32. Cl 14377

    33. Methotrexat-ebewe

    34. Tcmdc-125858

    35. (2s)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic Acid

    36. Abitrexate (methotrexate)

    37. R 9985

    38. Yl5fz2y5u1

    39. Methotextrate

    40. Methotrexat

    41. Chembl34259

    42. Nsc740

    43. Chebi:44185

    44. Adx-2191

    45. N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-l-glutamic Acid

    46. N-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)carbonyl]-l-glutamic Acid

    47. Cl14377

    48. Ncgc00025060-04

    49. Nsc 740

    50. 4-amino-n(10)-methylpteroylglutamic Acid

    51. A-methopterin

    52. Dsstox_cid_822

    53. A-methpterin

    54. Amethopterin L-

    55. Folex-pfs

    56. R-9985

    57. (2s)-2-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)formamido]pentanedioic Acid

    58. Dsstox_rid_75810

    59. Methotrexate, L-

    60. Dsstox_gsid_20822

    61. X 133

    62. Metotressato [dcit]

    63. Methotrexate, D-

    64. Fauldexato

    65. Medsatrexate

    66. Methoblastin

    67. Metotressato

    68. Brimexate

    69. Emthexat

    70. Emthexate

    71. Lantarel

    72. Lumexon

    73. Metrotex

    74. Novatrex

    75. Otrexup

    76. Tremetex

    77. Trexeron

    78. Trixilem

    79. Metex

    80. Texate

    81. Mls001401431

    82. Methotrexatum [inn-latin]

    83. Metotrexato [inn-spanish]

    84. [3h]methotrexate

    85. Smr000112001

    86. [3h]-methotrexate

    87. Folic Acid Antagonist

    88. Ccris 1109

    89. 4-aminomethylpteroylglutamic Acid

    90. Hsdb 3123

    91. L-(+)-n-(p-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)glutamic Acid

    92. N-(p-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-l-(+)-glutamic Acid

    93. Sr-01000075682

    94. Smr000449324

    95. Einecs 200-413-8

    96. Unii-yl5fz2y5u1

    97. Metolate

    98. Nordimet

    99. Ai3-25299

    100. Intradose-mtx

    101. 4-amino-n(sup 10)-methylpteroylglutamic Acid

    102. 1dhi

    103. 1dhj

    104. 2drc

    105. 4ocx

    106. (2s)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic Acid

    107. Cas-59-05-2

    108. Glutamic Acid, N-(p-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-, L-

    109. Kyselina N-(p-((2,4-diamino-6-pteridinylmethyl)methylamino)benzoyl)-l-glutamova

    110. Mpi-2505

    111. Prestwick_322

    112. Otrexup (tn)

    113. Xatmep (tn)

    114. Reditrex

    115. Kyselina 4-amino-n(sup 10)-methylpteroylglutamova [czech]

    116. Methylaminopterin; Mtx

    117. Methotrexate [usan:usp:inn:ban:jan]

    118. Spectrum_001836

    119. Tocris-1230

    120. 4kn0

    121. Wr-19039

    122. Prestwick0_000135

    123. Prestwick1_000135

    124. Prestwick2_000135

    125. Spectrum2_001077

    126. Spectrum3_000497

    127. Spectrum4_000616

    128. Spectrum5_000958

    129. Methotrexate - Abitrexate

    130. Methotrexate [mi]

    131. N-(p-(((2,4-diamino-6-pteridyl)methyl)methylamino)benzoyl)glutamic Acid

    132. Methotrexate [inn]

    133. Methotrexate [jan]

    134. L(+)-amethopterin Hydrate

    135. Methotrexate [hsdb]

    136. Methotrexate [iarc]

    137. Methotrexate [inci]

    138. Methotrexate [usan]

    139. N-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-l-glutamicacid

    140. Ncimech_000767

    141. Schembl3711

    142. Kyselina N-(p-((2,4-diamino-6-pteridinylmethyl)methylamino)benzoyl)-l-glutamova [czech]

    143. Methotrexate [vandf]

    144. Bidd:pxr0175

    145. Lopac0_000020

    146. Kbiogr_001172

    147. Kbioss_002341

    148. Methotrexate [mart.]

    149. Kyselina 4-amino-n(sup 10)-methylpteroylglutamova

    150. Mls000049968

    151. Mls002154208

    152. Divk1c_000114

    153. Methotrexate [usp-rs]

    154. Methotrexate [who-dd]

    155. Methotrexate [who-ip]

    156. Spbio_001094

    157. Spbio_002149

    158. Amy235

    159. Cid_126941

    160. Cid_165528

    161. Gtpl4674

    162. Gtpl4815

    163. Dtxsid4020822

    164. Schembl12421860

    165. Schembl23111732

    166. Bdbm18050

    167. Bdbm66082

    168. Hms500f16

    169. Kbio1_000114

    170. Kbio2_002338

    171. Kbio2_004906

    172. Kbio2_007474

    173. Kbio3_001493

    174. Methotrexate (jp17/usp/inn)

    175. G301

    176. Ninds_000114

    177. Bio1_000486

    178. Bio1_000975

    179. Bio1_001464

    180. Hms1568k12

    181. Hms2095k12

    182. Hms2233o18

    183. Hms3260c21

    184. Hms3414l09

    185. Hms3678l07

    186. Hms3712k12

    187. Methotrexate [orange Book]

    188. Methotrexate [ep Monograph]

    189. Methotrexate [usp Impurity]

    190. Act03341

    191. Apc-2002

    192. Bcp13701

    193. Mpi-5004

    194. Zinc1529323

    195. Methotrexate [usp Monograph]

    196. Tox21_110944

    197. Tox21_300269

    198. Tox21_500020

    199. Ccg-35800

    200. Emt-25299

    201. Methotrexatum [who-ip Latin]

    202. Mfcd00064370

    203. S1210

    204. Stl535338

    205. (4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzoyl)-l-glutamic Acid

    206. Akos016340329

    207. Tox21_110944_1

    208. Cs-1732

    209. Db00563

    210. Ks-5093

    211. Lp00020

    212. Sdccgsbi-0050009.p003

    213. Wr19039

    214. Idi1_000114

    215. N-(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}benzoyl)-l-glutamic Acid

    216. Smp2_000020

    217. (methyl)amino)benzamido)pentanedioic Acid

    218. Ncgc00025060-01

    219. Ncgc00025060-02

    220. Ncgc00025060-03

    221. Ncgc00025060-05

    222. Ncgc00025060-06

    223. Ncgc00025060-07

    224. Ncgc00025060-08

    225. Ncgc00025060-09

    226. Ncgc00025060-10

    227. Ncgc00025060-11

    228. Ncgc00025060-12

    229. Ncgc00025060-13

    230. Ncgc00025060-15

    231. Ncgc00025060-16

    232. Ncgc00254216-01

    233. Ncgc00260705-01

    234. Hy-14519

    235. Eu-0100020

    236. G-301

    237. Sw198601-3

    238. Methotrexate 1.0 Mg/ml In Dimethyl Sulfoxide

    239. 73m731

    240. A10021

    241. C01937

    242. D00142

    243. Q422232

    244. Sr-01000597411

    245. W-60383

    246. (s)-2-(4-(((2,4-diaminopteridin-6-yl)methyl)

    247. Q-201366

    248. Sr-01000075682-1

    249. Sr-01000075682-2

    250. Sr-01000075682-6

    251. Sr-01000597411-1

    252. W-105347

    253. Brd-k59456551-001-09-3

    254. Brd-k59456551-001-11-9

    255. Wln: T66 Bn Dn Gn Jnj Cz Ez H1n1&r Dvmyvq2vq

    256. Z1541638527

    257. N,n,n,n-ethylenediaminetetra(methylenephosphonicacid)

    258. Methotrexate, European Pharmacopoeia (ep) Reference Standard

    259. Methotrexate, United States Pharmacopeia (usp) Reference Standard

    260. Glutamic Acid,4-diamino-6-pteridinyl)methyl] Methylamino]benzoyl]-, L-(+)-

    261. L-glutamic Acid,4-diamino-6-pteridinyl)methyl]- Methylamino]benzoyl]-

    262. (s)-2-(4-(((2,4-diaminopteridin-6-yl)methyl)-(methyl)amino)benzamido)pentanedioic Acid

    263. L-glutamic Acid,n-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-,hydrate(9ci)

    264. Methotrexate For Peak Identification, European Pharmacopoeia (ep) Reference Standard

    265. Methotrexate For System Suitability, European Pharmacopoeia (ep) Reference Standard

    266. Methotrexate, Pharmaceutical Secondary Standard; Certified Reference Material

    267. N-[4-[[(2,4-diamino-6-pteridinyl)methyl] Methylamino]benzoyl]-l-glutamic Acid

    268. (2s)-2-((4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzoyl)amino)pentanedioic Acid

    269. (2s)-2-[[[4-[(2,4-diamino-6-pteridinyl)methyl-methylamino]phenyl]-oxomethyl]amino]pentanedioic Acid;hydrate

    270. (2s)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]glutaric Acid;hydrate

    271. (2s)-2-[[4-[[2,4-bis(azanyl)pteridin-6-yl]methyl-methyl-amino]phenyl]carbonylamino]pentanedioic Acid;hydrate

    272. 102613-64-9

    273. L-glutamic Acid,n-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, Hydrate (9ci)

    274. Methotrexate, Pharmagrade, Manufactured Under Appropriate Controls For Use As A Raw Material In Pharma Or Biopharmaceutical Production, Meets Ep, Usp Testing Specifications

    2.4 Create Date
    2005-06-24
    3 Chemical and Physical Properties
    Molecular Weight 454.4 g/mol
    Molecular Formula C20H22N8O5
    XLogP3-1.8
    Hydrogen Bond Donor Count5
    Hydrogen Bond Acceptor Count12
    Rotatable Bond Count9
    Exact Mass454.17131583 g/mol
    Monoisotopic Mass454.17131583 g/mol
    Topological Polar Surface Area211 Ų
    Heavy Atom Count33
    Formal Charge0
    Complexity704
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 4  
    Drug NameMethotrexate sodium
    Drug LabelMethotrexate (formerly Amethopterin) is an antimetabolite used in the treatment of certain neoplastic diseases, severe psoriasis, and adult rheumatoid arthritis. Chemically methotrexate is N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-...
    Active IngredientMethotrexate sodium
    Dosage FormTablet; Injectable
    RouteInjection; Oral
    Strengtheq 200mg base/8ml (eq 25mg base/ml); eq 250mg base/10ml (eq 25mg base/ml); eq 50mg base/2ml (eq 25mg base/ml); eq 2.5mg base; eq 100mg base/4ml (eq 25mg base/ml)
    Market StatusPrescription
    CompanyHospira; Roxane; Dava Pharms; Fresenius Kabi Usa; Eurohlth Intl; Mylan; Barr

    2 of 4  
    Drug NameTrexall
    PubMed HealthMethotrexate
    Drug ClassesAntineoplastic Agent, Antipsoriatic, Antirheumatic, Antirheumatic, Cytotoxic
    Drug LabelTrexall (methotrexate tablets USP) (formerly Amethopterin) is an antimetabolite used in the treatment of certain neoplastic diseases, severe psoriasis, and adult rheumatoid arthritis. Chemically methotrexate, USP is N-[4[[(2,4-diamino-6-pteridiny...
    Active IngredientMethotrexate sodium
    Dosage FormTablet
    RouteOral
    Strengtheq 5mg base; eq 7.5mg base; eq 15mg base; eq 10mg base
    Market StatusPrescription
    CompanyBarr

    3 of 4  
    Drug NameMethotrexate sodium
    Drug LabelMethotrexate (formerly Amethopterin) is an antimetabolite used in the treatment of certain neoplastic diseases, severe psoriasis, and adult rheumatoid arthritis. Chemically methotrexate is N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-...
    Active IngredientMethotrexate sodium
    Dosage FormTablet; Injectable
    RouteInjection; Oral
    Strengtheq 200mg base/8ml (eq 25mg base/ml); eq 250mg base/10ml (eq 25mg base/ml); eq 50mg base/2ml (eq 25mg base/ml); eq 2.5mg base; eq 100mg base/4ml (eq 25mg base/ml)
    Market StatusPrescription
    CompanyHospira; Roxane; Dava Pharms; Fresenius Kabi Usa; Eurohlth Intl; Mylan; Barr

    4 of 4  
    Drug NameTrexall
    PubMed HealthMethotrexate
    Drug ClassesAntineoplastic Agent, Antipsoriatic, Antirheumatic, Antirheumatic, Cytotoxic
    Drug LabelTrexall (methotrexate tablets USP) (formerly Amethopterin) is an antimetabolite used in the treatment of certain neoplastic diseases, severe psoriasis, and adult rheumatoid arthritis. Chemically methotrexate, USP is N-[4[[(2,4-diamino-6-pteridiny...
    Active IngredientMethotrexate sodium
    Dosage FormTablet
    RouteOral
    Strengtheq 5mg base; eq 7.5mg base; eq 15mg base; eq 10mg base
    Market StatusPrescription
    CompanyBarr

    4.2 Therapeutic Uses

    Abortifacient Agents, Nonsteroidal; Antimetabolites, Antineoplastic; Antirheumatic Agents; Dermatologic Agents; Enzyme Inhibitors; Folic Acid Antagonists; Immunosuppressive Agents; Nucleic Acid Synthesis Inhibitors

    National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)

    Methotrexate is indicated for treatment of breast carcinoma, head and neck cancers (epidermoid), non-small cell lung carcinoma (especially squamous cell types), small cell lung carcinoma, and gestational trophoblastic tumors (gestational choriocarcinoma, chorioadenoma destruens, hydatidiform mole). /Included in US product labeling/

    Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004., p. 1911

    Methotrexate is indicated for treatment of cervical carcinoma, ovarian carcinoma, bladder carcinoma, colorectal carcinoma, esophageal carcinoma, gastric carcinoma, pancreatic carcinoma, and penile carcinoma. /NOT included in US product labeling/

    Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004., p. 1911

    Methotrexate is indicated for treatment of acute lymphocytic leukemia and prophylaxis and treatment of meningeal leukemia. /Included in US product labeling/

    Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004., p. 1911

    For more Therapeutic Uses (Complete) data for METHOTREXATE (17 total), please visit the HSDB record page.

    4.3 Drug Warning

    Methotrexate is a highly toxic drug with a very low therapeutic index and a therapeutic response is not likely to occur without some evidence of toxicity. ... When methotrexate is used in combination with other antineoplastic agents and/or radiation therapy, toxic reactions may be more severe than would occur with methotrexate therapy alone. Although doses of methotrexate used in the management of psoriasis and rheumatoid arthritis are usually lower than those used in antineoplastic chemotherapy, severe toxicity may occur in any patient receiving the drug and deaths have been reported with the use of methotrexate in the management of psoriasis and rheumatoid arthritis.

    McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2005. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2005 (Plus Supplements)., p. 1111

    Methotrexate should be used with extreme caution in patients with infection, peptic ulcer, ulcerative colitis, or debility, and in very young or geriatric patients. Methotrexate should be used with extreme caution, if at all, in patients with malignant disease who have preexisting liver damage or impaired hepatic function, preexisting bone marrow depression, aplasia, leukopenia, thrombocytopenia, or anemia; the drug is usually contraindicated in patients with impaired renal function. In the management of psoriasis, methotrexate is contraindicated in patients with poor nutritional status or severe renal or hepatic disorders, those with overt or laboratory evidence of an immunodeficiency syndrome, and in those with preexisting blood dyscrasias such as bone marrow hypoplasia, leukopenia, thrombocytopenia, or clinically important anemia; relative contraindications also include cirrhosis, active or recent hepatitis, or excessive alcohol consumption. In the management of rheumatoid arthritis, methotrexate is contraindicated in patients with preexisting blood dyscrasias such as bone marrow hypoplasia, leukopenia, thrombocytopenia, or clinically important anemia; those with overt or laboratory evidence of immunodeficiency syndromes; and those with excessive alcohol consumption, alcoholic liver disease, or chronic liver disease.

    McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2005. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2005 (Plus Supplements)., p. 1112

    Elevations in serum uric acid concentrations may occur in patients receiving methotrexate as a result of cell destruction and hepatic and renal damage. In some patients, uric acid nephropathy and acute renal failure may result. Tumor lysis syndrome associated with other cytotoxic drugs (e.g., fludarabine, cladribine), also has been reported in patients with rapidly growing tumors who were receiving methotrexate. Pharmacologic and appropriate supportive treatment may prevent or alleviate this complication. Methotrexate also was reported to precipitate acute gouty arthritis in two patients being treated for psoriasis. Administration of large volumes of fluids, alkalinization of the urine, and/or administration of allopurinol may be useful in preventing acute attacks of hyperuricemia and uric acid nephropathy.

    McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2005. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2005 (Plus Supplements)., p. 1111

    Severe nephropathy manifested by azotemia, hematuria, and renal failure may occur in patients receiving methotrexate; fatalities have been reported. In one study, postmortem examination revealed extensive necrosis of the epithelium of the convoluted tubules. In patients with renal impairment, methotrexate accumulation and increased toxicity or additional renal damage may occur.

    McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2005. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2005 (Plus Supplements)., p. 1111

    For more Drug Warnings (Complete) data for METHOTREXATE (22 total), please visit the HSDB record page.

    4.4 Drug Indication

    Methotrexate oral solution is indicated for pediatric acute lymphoblastic leukemia and pediatric polyarticular juvenile idiopathic arthritis. Methotrexate injections for subcutaneous use are indicated for severe active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and severe, recalcitrant, disabling psoriasis. Other formulations are indicated to treat gestational choriocarcinoma, chorioadenoma destruens, hydatiform mole, breast cancer, epidermoid cancer of the head and neck, advanced mycosis fungoides, lung cancer, and advanced non-Hodgkin's lymphoma. It is also used in the maintenance of acute lymphocytic leukemia. Methotrexate is also given before treatment with leucovorin to prolong relapse-free survival following surgical removal of a tumour in non-metastatic osteosarcoma.

    FDA Label

    Nordimet is indicated for the treatment of:

    - active rheumatoid arthritis in adult patients,

    - polyarthritic forms of severe, active juvenile idiopathic arthritis (JIA), when the response to nonsteroidal anti-inflammatory drugs (NSAIDs) has been inadequate,

    - severe recalcitrant disabling psoriasis, which is not adequately responsive to other forms of therapy such as phototherapy, psoralens and ultraviolet A (PUVA), and retinoids, and severe psoriatic arthritis in adult patients,

    - induction of remission in moderate steroid-dependent Crohn's disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.

    5 Pharmacology and Biochemistry
    5.1 Pharmacology

    Methotrexate inhibits enzymes responsible for nucleotide synthesis which prevents cell division and leads to anti-inflammatory actions. It has a long duration of action and is generally given to patients once weekly. Methotrexate has a narrow therapeutic index. Do not take methotrexate daily.

    5.2 MeSH Pharmacological Classification

    Abortifacient Agents, Nonsteroidal

    Non-steroidal chemical compounds with abortifacient activity. (See all compounds classified as Abortifacient Agents, Nonsteroidal.)

    Enzyme Inhibitors

    Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)

    Antimetabolites, Antineoplastic

    Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)

    Immunosuppressive Agents

    Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)

    Antirheumatic Agents

    Drugs that are used to treat RHEUMATOID ARTHRITIS. (See all compounds classified as Antirheumatic Agents.)

    Dermatologic Agents

    Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)

    Folic Acid Antagonists

    Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Folic Acid Antagonists.)

    Nucleic Acid Synthesis Inhibitors

    Compounds that inhibit cell production of DNA or RNA. (See all compounds classified as Nucleic Acid Synthesis Inhibitors.)

    5.3 FDA Pharmacological Classification
    5.3.1 Active Moiety
    METHOTREXATE
    5.3.2 FDA UNII
    YL5FZ2Y5U1
    5.3.3 Pharmacological Classes
    Copper-containing Intrauterine Device [EPC]; Decreased Embryonic Implantation [PE]; Decreased Sperm Motility [PE]; Inhibit Ovum Fertilization [PE]; Copper [CS]
    5.4 ATC Code

    L04AX03

    L04AX03

    S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355

    L - Antineoplastic and immunomodulating agents

    L01 - Antineoplastic agents

    L01B - Antimetabolites

    L01BA - Folic acid analogues

    L01BA01 - Methotrexate

    L - Antineoplastic and immunomodulating agents

    L04 - Immunosuppressants

    L04A - Immunosuppressants

    L04AX - Other immunosuppressants

    L04AX03 - Methotrexate

    5.5 Absorption, Distribution and Excretion

    Absorption

    Methotrexate has a bioavailability of 64-90%, though this decreases at oral doses above 25mg due to saturation of the carrier mediated transport of methotrexate.. Methotrexate has a Tmax of 1 to 2 hours. oral doses of 10-15g reach serum levels of 0.01-0.1M.

    Route of Elimination

    Methotrexate is >80% excreted as the unchanged drug and approximately 3% as the 7-hydroxylated metabolite. Methotrexate is primarily excreted in the urine with 8.7-26% of an intravenous dose appearing in the bile.

    Volume of Distribution

    The volume of distribution of methotrexate at steady state is approximately 1L/kg.

    Clearance

    Methotrexate clearance varies widely between patients and decreases with increasing doses. Currently, predicting clearance of methotrexate is difficult and exceedingly high serum levels of methotrexate can still occur when all precautions are taken.

    In adults, oral absorption of methotrexate appears to be dose dependent. Peak serum levels are reached within one to two hours. At doses of 30 mg/sq m or less, methotrexate is generally well absorbed with a mean bioavailability of about 60%. The absorption of doses greater than 80 mg/sq m is significantly less, possibly due to a saturation effect.

    Physicians Desk Reference. 58th ed. Thomson PDR. Montvale, NJ 2004., p. 806

    After intravenous administration, the initial volume of distribution is approximately 0.18 L/kg (18% of body weight) and steady-state volume of distribution is approximately 0.4 to 0.8 L/kg (40% to 80% of body weight).

    Physicians Desk Reference. 58th ed. Thomson PDR. Montvale, NJ 2004., p. 806

    Protein binding: Moderate (approximately 50%), primarily to albumin.

    Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004., p. 1912

    At serum methotrexate concentrations exceeding 0.1 umol/mL passive diffusion becomes a major means of intracellular transport of the drug. The drug is widely distributed into body tissues with highest concn in the kidneys, gallbladder, spleen, liver, and skin.

    McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2005. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2005 (Plus Supplements)., p. 1113

    For more Absorption, Distribution and Excretion (Complete) data for METHOTREXATE (10 total), please visit the HSDB record page.

    5.6 Metabolism/Metabolites

    Methotrexate is metabolized by folylpolyglutamate synthase to methotrexate polyglutamate in the liver as well as in tissues. Gamma-glutamyl hydrolase hydrolyzes the glutamyl chains of methotrexate polyglutamates converting them back to methotrexate. A small amount of methotrexate is also converted to 7-hydroxymethotrexate.

    After absorption, methotrexate undergoes hepatic and intracellular metabolism to form methotrexate polyglutamate, metabolites which by hydrolysis may be converted back to methotrexate. Methotrexate polyglutamates inhibit dihydrofolate reductase and thymidylate synthetase. Small amounts of these polyglutamate metabolites may remain in tissues for extended periods; the retention and prolonged action of these active metabolites vary among different cells, tissues, and tumors. In addition, small amounts of methotrexate polyglutamate may be converted to 7-hydroxymethotrexate; accumulation of this metabolite may become substantial following administration of high doses of methotrexate, since the aqueous solubility of 7-hydroxymethotrexate is threefold to fivefold lower than that of the parent compound. Following oral administration of methotrexate, the drug also is partially metabolized by the intestinal flora.

    McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2005. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2005 (Plus Supplements)., p. 1113

    5.7 Biological Half-Life

    The half life of low dose methotrexate is 3 to 10 hours in adults. The half life for high dose methotrexate is 8 to 15 hours. Pediatric patients taking methotrexate for acute lymphoblastic anemia experience a terminal half life of 0.7 to 5.8 hours. Pediatric patients taking methotrexate for juvenile idiopathic arthritis experience a half life of 0.9 to 2.3 hours.

    Terminal: Low doses: 3 to 10 hours. High doses: 8 to 15 hours. Note: There is wide interindividual variation in clearance rates. Small amounts of methotrexate and its metabolites are protein-bound and may remain in tissues (kidneys, liver) for weeks to months; the presence of fluid loads, such as ascites or pleural effusion, and renal function impairment will also delay clearance.

    Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004., p. 1912

    5.8 Mechanism of Action

    Methotrexate enters tissues and is converted to a methotrexate polyglutamate by folylpolyglutamate. Methotrexate's mechanism of action is due to its inhibition of enzymes responsible for nucleotide synthesis including dihydrofolate reductase, thymidylate synthase, aminoimidazole caboxamide ribonucleotide transformylase (AICART), and amido phosphoribosyltransferase. Inhibtion of nucleotide synthesis prevents cell division. In rheumatoid arthritis, methotrexate polyglutamates inhibit AICART more than methotrexate. This inhibition leads to accumulation of AICART ribonucleotide, which inhibits adenosine deaminase, leading to an accumulation of adenosine triphosphate and adenosine in the extracellular space, stimulating adenosine receptors, leading to anti-inflammatory action.

    Methotrexate and its polyglutanate metabolites reversibly inhibits dihydrofolate reductase, the enzyme that reduces folic acid to tetrahydrofolic acid. Inhibition of tetrahydrofolate formation limits the availability of one-carbon fragments necessary for synthesis of purines and the conversion of deoxyuridylate to thymidylate in the synthesis of DNA and cell reproduction. The affinity of dihydrofolate reductase for methotrexate is far greater than its affinity for folic acid or dihydrofolic acid. and, therefore, even very large doses of folic acid given simultaneously will not reverse the effects of methotrexate. Leucovorin calcium, a derivative of tetrahydrofolic acid, may block the effects of methotrexate if given shortly after the antineoplastic agent. Results of one study indicate that methotrexate also causes an increase in intracellular deoxyadenosine triphosphate, which is thought to inhibit ribonucleotide reduction, and polynucleotide ligase, an enzyme concerned in DNA synthesis and repair. Tissues with high rates of cellular proliferation such as neoplasms, psoriatic epidermis, bone marrow, the lining of the GI tract, hair matrix, and fetal cells are most sensitive to the effects of methotrexate.

    McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2005. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2005 (Plus Supplements)., p. 1113

    Methotrexate ... has immunosuppressive activity, in part possibly as a result of inhibition of lymphocyte multiplication. The mechanism(s) of action in the management of rheumatoid arthritis of the drug is not known, although suggested mechanisms have included immunosuppressive and/or antiinflammatory effects.

    McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2005. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2005 (Plus Supplements)., p. 1113

    API SUPPLIERS

    read-more
    read-more

    01

    Fermion Oy

    Finland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BOS Manchester
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothWith Fermion, start the journey of your innovative API.

    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-04-28

    Pay. Date : 2014-04-17

    DMF Number : 23532

    Submission : 2010-01-29

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 12780-0491

    Start Marketing Date : 1981-11-19

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

     KDMF VMF ASMF, BR arrow-down
    ✖
    Available Reg Filing : ASMF, BR
    AUDIT
    fermion

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Pfanstiehl

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothPfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 39988

    Submission : 2024-06-05

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Pfanstiehl

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Rochem International Inc

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Suppliers Night Expo
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Rochem

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    LGM Pharma

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    LGM Pharma CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Cohance Lifesciences

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI India 2024
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Cohance

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Fareva

    Luxembourg

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BOS Manchester
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothFareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Contact Supplier Contact Supplier
    Flag Luxembourg
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-10-04

    Pay. Date : 2013-09-26

    DMF Number : 11704

    Submission : 1995-10-05

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R0-CEP 2022-373 - Rev 00

    Issue Date : 2022-12-13

    Type : Chemical

    Substance Number : 560

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 219MF10360

    Registrant's Address : NUERNBERGER STRASSE 12, 90537 FEUCHT, GERMANY

    Initial Date of Registration : 2007-12-13

    Latest Date of Registration : --

     EU-WC NDC arrow-down
    ✖

    NDC Package Code : 46014-1023

    Start Marketing Date : 2013-05-06

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING

     KDMF VMF ASMF, CN arrow-down
    ✖
    Available Reg Filing : ASMF, CN
    AUDIT
    Fareva Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Jai Radhe Sales

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI India 2024
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Jai Radhe Sales

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    CF Pharma

    Hungary

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothCF Pharma- skilled & highly experienced European API producer based in Hungary.

    Contact Supplier Contact Supplier
    Flag Hungary
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 25957

    Submission : 2012-04-10

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2008-238 - Rev 02

    Issue Date : 2020-02-07

    Type : Chemical

    Substance Number : 560

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    CF Pharma

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    HRV Global Life Sciences

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI India 2024
    Booth #2.D38
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothHRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    HRV Global Life Sciences

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Sichuan Elixir Pharmaceuticals

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSichuan Elixir Pharmaceutical, a manufacturer of small molecule APIs & a CMO/CDMO service provider for anti-tumor characteristic APIs..

    Contact Supplier Contact Supplier
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 39758

    Submission : 2024-03-24

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Sichuan Elixir Pharmaceuticals

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    USDMF

    read-more
    read-more

    01

    Fermion Oy

    Finland
    arrow
    BOS Manchester
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothWith Fermion, start the journey of your innovative API.

    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : Complete

    Rev. Date : 2014-04-28

    Pay. Date : 2014-04-17

    DMF Number : 23532

    Submission : 2010-01-29

    Status : Active

    Type : II

    fermion

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Fermion Oy

    Finland
    arrow
    BOS Manchester
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothWith Fermion, start the journey of your innovative API.

    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : Complete

    Rev. Date : 2013-06-08

    Pay. Date : 2013-05-23

    DMF Number : 4246

    Submission : 1981-08-06

    Status : Active

    Type : II

    fermion

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Pfanstiehl Inc

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothPfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 39988

    Submission : 2024-06-05

    Status : Active

    Type : II

    Pfanstiehl

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Excella Gmbh And Co Kg

    Luxembourg
    arrow
    BOS Manchester
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothFareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Contact Supplier Contact Supplier
    Flag Luxembourg
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : Complete

    Rev. Date : 2013-10-04

    Pay. Date : 2013-09-26

    DMF Number : 11704

    Submission : 1995-10-05

    Status : Active

    Type : II

    Fareva Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Excella Gmbh And Co Kg

    Luxembourg
    arrow
    BOS Manchester
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothFareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Contact Supplier Contact Supplier
    Flag Luxembourg
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : Complete

    Rev. Date : 2018-11-26

    Pay. Date : 2018-11-16

    DMF Number : 12472

    Submission : 1997-04-11

    Status : Active

    Type : II

    Fareva Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Cf Pharma Ltd

    Hungary
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothCF Pharma- skilled & highly experienced European API producer based in Hungary.

    Contact Supplier Contact Supplier
    Flag Hungary
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 25957

    Submission : 2012-04-10

    Status : Active

    Type : II

    CF Pharma

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Sichuan Elixir Pharmaceutical Co Ltd

    China
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSichuan Elixir Pharmaceutical, a manufacturer of small molecule APIs & a CMO/CDMO service provider for anti-tumor characteristic APIs..

    Contact Supplier Contact Supplier
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 39758

    Submission : 2024-03-24

    Status : Active

    Type : II

    Sichuan Elixir Pharmaceuticals

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Fi Europe 2024
    Not Confirmed

    08

    Ben Venue Laboratories Inc

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 6122

    Submission : 1985-12-12

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Pfizer Ltd

    Japan

    USDMF

    arrow
    Fi Europe 2024
    Not Confirmed

    09

    Pfizer Ltd

    Japan
    arrow
    Fi Europe 2024
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 4018

    Submission : 1980-11-11

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Lederle Laboratories Div American Cy...

    Country

    USDMF

    arrow
    Fi Europe 2024
    Not Confirmed

    10

    Lederle Laboratories Div American Cy...

    Country
    arrow
    Fi Europe 2024
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 3124

    Submission : 1978-02-03

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    NDC API

    read-more
    read-more

    01

    Fermion Oy

    Finland
    arrow
    BOS Manchester
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothWith Fermion, start the journey of your innovative API.

    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    METHOTREXATE SODIUM

    NDC Package Code : 12780-6690

    Start Marketing Date : 2010-01-14

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    fermion

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Fermion Oy

    Finland
    arrow
    BOS Manchester
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothWith Fermion, start the journey of your innovative API.

    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    METHOTREXATE

    NDC Package Code : 12780-0491

    Start Marketing Date : 1981-11-19

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    fermion

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Excella GmbH & Co. KG

    Luxembourg
    arrow
    BOS Manchester
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothFareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Contact Supplier Contact Supplier
    Flag Luxembourg
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    METHOTREXATE

    NDC Package Code : 46014-1023

    Start Marketing Date : 2013-05-06

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT FOR HUMAN P...

    Fareva Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Excella GmbH & Co. KG

    Luxembourg
    arrow
    BOS Manchester
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothFareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Contact Supplier Contact Supplier
    Flag Luxembourg
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    METHOTREXATE

    NDC Package Code : 46014-1133

    Start Marketing Date : 2017-11-29

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    Fareva Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Excella GmbH & Co. KG

    Luxembourg
    arrow
    BOS Manchester
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothFareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Contact Supplier Contact Supplier
    Flag Luxembourg
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    METHOTREXATE SODIUM

    NDC Package Code : 46014-1119

    Start Marketing Date : 2013-06-12

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    Fareva Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Alembic Pharmaceuticals Limited

    India
    Fi Europe 2024
    Not Confirmed
    arrow

    Alembic Pharmaceuticals Limited

    India
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    METHOTREXATE SODIUM

    NDC Package Code : 46708-939

    Start Marketing Date : 2024-01-29

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : BULK INGREDIENT

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Huzhou Zhanwang Pharmaceutical Co. ...

    China
    Fi Europe 2024
    Not Confirmed
    arrow

    Huzhou Zhanwang Pharmaceutical Co. ...

    China
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    METHOTREXATE

    NDC Package Code : 63660-0006

    Start Marketing Date : 2017-12-18

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Professional Compounding Centers of...

    United Kingdom
    Fi Europe 2024
    Not Confirmed
    arrow

    Professional Compounding Centers of...

    United Kingdom
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    METHOTREXATE

    NDC Package Code : 51927-1565

    Start Marketing Date : 2013-06-24

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT FOR HUMAN P...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Spectrum Laboratory Products, Inc.

    U.S.A
    Fi Europe 2024
    Not Confirmed
    arrow

    Spectrum Laboratory Products, Inc.

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    METHOTREXATE

    NDC Package Code : 49452-4601

    Start Marketing Date : 2000-12-01

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1g/g)

    Marketing Category : BULK INGREDIENT

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Zhejiang Hisun Pharmaceutical Co., ...

    China
    Fi Europe 2024
    Not Confirmed
    arrow

    Zhejiang Hisun Pharmaceutical Co., ...

    China
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    METHOTREXATE

    NDC Package Code : 58623-0040

    Start Marketing Date : 2012-03-29

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Listed Suppliers

    read-more
    read-more

    01

    Fermion Oy

    Finland
    arrow
    BOS Manchester
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothWith Fermion, start the journey of your innovative API.

    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Methotrexate

    About the Company : Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a fully integrated CDMO & offer services covering both APIs & F...

    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a fully integrated CDMO & offer services covering both APIs & Formulations. API portfolio consists of >30 generic APIs & >10 NCEs & 2 mfg. sites as well as R&D facilities are all located in Finland. Fermion has invested & expanded capabilities in the production of HPAPIs. Drug product CMO services include hormonal & non-hormonal semi-solids, cytotoxic oral solids & packaging. We have 3 mfg. sites & one packaging center for drug products at Orion.
    fermion

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Pfanstiehl

    U.S.A
    arrow
    BMWS24
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothPfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Methotrexate

    About the Company : Transform your biologic formulations with Pfanstiehl, the industry leader in High-Purity Low Endotoxin Low Metals Parenteral grade excipient manufacturing. Our expertise spans isol...

    Transform your biologic formulations with Pfanstiehl, the industry leader in High-Purity Low Endotoxin Low Metals Parenteral grade excipient manufacturing. Our expertise spans isolation, purification, custom synthesis, and scale-up development, ensuring the highest quality injectable formulation ingredients. Whether you need gram-scale quantities or multi-ton batches, trust Pfanstiehl for the highest quality injectable grade excipients available. The leading pharmaceutical companies worldwide use Pfanstiehl excipients for their unmatched purity, lowest endotoxin, and minimal trace metals. Partner with us to elevate your biologics formulations
    Pfanstiehl

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Rochem International Inc

    U.S.A
    arrow
    Suppliers Night Expo
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Methotrexate

    About the Company : Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quali...

    Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quality ingredients manufactured in China. Headquartered in the Hauppauge, New York, Rochem has 16 offices spread across the globe to cater to the needs of its customers. Rochem’s operations are fully cGMP compliant and has been audited by the USFDA as well as several multinational organizations. It also trains and audits its partners to ensure all of their technologies and systems are FDA-compliant.
    Rochem

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    LGM Pharma

    U.S.A
    arrow
    BMWS24
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Methotrexate

    About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...

    LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, analytical method development and testing, and commercial manufacturing. LGM Pharma offers custom API synthesis, analytical development, and regulatory services. With a network of over 300 accredited CGMP manufacturing partners, LGM provides unparalleled supply chain security. And, with over 100,000 square feet of FDA-inspected cGMP manufacturing and warehouse capacity, LGM Pharma provides a one-stop solution for solid dose, powder, semi-solid and liquid drugs.
    LGM Pharma CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Cohance Lifesciences

    India
    arrow
    CPhI India 2024
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Methotrexate

    About the Company : Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialzation. With our...

    Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialzation. With our expertise in complex chemistries, we provide end-to-end CDMO services to global innovators and have delivered numerous projects from concept to commercialization over the years.As a global API player, we serve customers across nearly 60 countries with 80+ molecules backed by robust R&D, regulatory capabilities and manufacturing infrastructure. We are among the top backward integrated exporters of pellets and have strong development and manufacturing capabilities.
    Cohance

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Fareva

    Luxembourg
    arrow
    BOS Manchester
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothFareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Contact Supplier Contact Supplier
    Flag Luxembourg
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Methotrexate

    About the Company : Fareva’s API division has special technologies for high potent APIs (HPAPIs) down to the OEB-6 level, aseptic crystallization (sterile APIs), Spray Drying etc, with volumes rangi...

    Fareva’s API division has special technologies for high potent APIs (HPAPIs) down to the OEB-6 level, aseptic crystallization (sterile APIs), Spray Drying etc, with volumes ranging from a few kgs to multi tons production. Fareva’s Drug Product division offers different technologies: injectables (lyophilized, solution, suspension, vial, ampoules, pre-filled syringes), unidoses and multidoses BFS, solids (tablets, hard capsules, powders), semi-solids (cream, gel suppositories) and liquids (oral and external, sprays, aerosols).
    Fareva Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Jai Radhe Sales

    India
    arrow
    CPhI India 2024
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Methotrexate

    About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...

    Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete sourcing solutions for pharmaceutical products from India, including technical and regulatory assistance. It believes in providing its customers with high-quality products at reasonable prices. It has always endeavored to achieve global standards in the field of pharmaceuticals and has carved out a niche for itself through new methods based on current market needs. Today, it has established itself as a truly global company, with exports to almost every continent.
    Jai Radhe Sales

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    CF Pharma

    Hungary
    arrow
    BMWS24
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothCF Pharma- skilled & highly experienced European API producer based in Hungary.

    Contact Supplier Contact Supplier
    Flag Hungary
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Methotrexate

    About the Company : Established in 1996, CF Pharma Ltd. is a privately owned, independent developer & producer of APIs headquartered in Budapest, Hungary. It specializes in the development & manufactu...

    Established in 1996, CF Pharma Ltd. is a privately owned, independent developer & producer of APIs headquartered in Budapest, Hungary. It specializes in the development & manufacturing of high-quality, complex APIs & advanced intermediates with proven experience in handling complex & hazardous chemistry, making it a partner of choice in the development of “difficult to make” molecules. Since 1999, 25 API manufacturing processes have been developed in its three R&D labs. It specializes in quality control & regulatory compliance, & has consistently done well in regular inspections carried out by the Hungarian authority & European agencies.
    CF Pharma

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    HRV Global Life Sciences

    India
    arrow
    CPhI India 2024
    Booth #2.D38
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothHRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Methotrexate

    About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...

    HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It offers services such as sourcing, manufacturing & supply, helping partners enter new markets worldwide. Its strong partnerships with major players in the pharma and food additive industries help HRV Global effectively promote projects and products. HRV Global represents over 30 large Indian drugmakers, primarily targeting Europe, the US & the Middle East markets. Headquartered in India, HRV Global has offices in the US, Switzerland, Dubai, Lithuania & Turkey.
    HRV Global Life Sciences

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Sichuan Elixir Pharmaceuticals

    China
    arrow
    BMWS24
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSichuan Elixir Pharmaceutical, a manufacturer of small molecule APIs & a CMO/CDMO service provider for anti-tumor characteristic APIs..

    Contact Supplier Contact Supplier
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Methotrexate

    About the Company : Specializing in natural & oncology APIs, we establish R&D and production platforms for new salt, crystal form & synthetic biology research. We cooperate with clients for IND, NDA, ...

    Specializing in natural & oncology APIs, we establish R&D and production platforms for new salt, crystal form & synthetic biology research. We cooperate with clients for IND, NDA, ANDA, 505b(2) and P-IV challenges. Exploring macromolecular APIs, we focus on Glycans & polypeptides. Expertise in XDC drugs drives innovative research & payload production. With a global registration platform & international cGMP system, we offer API CMO/CDMO services worldwide. Our strategy combines FDF and APIs. Our labs meet GMP standards with a stable R&D team, over 10 years of experience, we've delivered 20+ successful projects.
    Sichuan Elixir Pharmaceuticals

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1677609000,"product":"METHOTREXATE","address":"304, TOWN CENTRE, ANDHERI KURLA ROAD, ANDHERI EAST","city":"MUMBAI","supplier":"MAC-CHEM PRODUCTS (INDIA) PVT.LTD","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"RENATA LTD,","customerCountry":"BANGLADESH","quantity":"0.35","actualQuantity":"0.35","unit":"KGS","unitRateFc":"6000","totalValueFC":"2091.2","currency":"USD","unitRateINR":491428.57142857148,"date":"01-Mar-2023","totalValueINR":"172000","totalValueInUsd":"2091.2","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"8173915","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"304, TOWN CENTRE, ANDHERI KURLA ROAD, ANDHERI EAST, MUMBAI","customerAddress":""},{"dataSource":"API Import","activeIngredients":"METHOTREXATE","year":"2021","qtr":"Q1","strtotime":1611858600,"product":"METHOTREXATE USP\/EP\/IP\/BP","address":"NAIR BAUG, AKURLI ROADKANDIVILI EAST","city":"MUMBAI ,MAHARASHTRA","supplier":"FERMION OY","supplierCountry":"FINLAND","foreign_port":"","customer":"BDH INDUSTRIES LIMITED","customerCountry":"INDIA","quantity":"40.00","actualQuantity":"40","unit":"KGS","unitRateFc":"3200","totalValueFC":"157775.5","currency":"EUR","unitRateINR":"288480","date":"29-Jan-2021","totalValueINR":"11539200","totalValueInUsd":"157775.5","indian_port":"BOMBAY AIR","hs_no":"29335990","bill_no":"2549865","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"","supplierAddress":"","customerAddress":"NAIR BAUG, AKURLI ROADKANDIVILI EAST"},{"dataSource":"API Import","activeIngredients":"METHOTREXATE","year":"2021","qtr":"Q2","strtotime":1621449000,"product":"METHOTREXATE USP","address":"S.C.O.857, CABIN NO. 10, 2ND FLOOR,NAC, MANIMAJRA,","city":"CHANDIGARH.","supplier":"HANGZHOU ZHONGBAO IMP.&EXP.CORP. ","supplierCountry":"CHINA","foreign_port":"HONG KONG","customer":"VENUS REMEDIES","customerCountry":"INDIA","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"2750","totalValueFC":"296.5","currency":"USD","unitRateINR":"217217","date":"20-May-2021","totalValueINR":"21721.7","totalValueInUsd":"296.5","indian_port":"DELHI AIR","hs_no":"29419090","bill_no":"4020326","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HONG KONG","supplierAddress":"","customerAddress":"S.C.O.857, CABIN NO. 10, 2ND FLOOR,NAC, MANIMAJRA,"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1627065000,"product":"METHOTREXATE DISODIUM","address":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR","city":"AHMEDABAD\/GUJRAT","supplier":"FERMION OY","supplierCountry":"FINLAND","foreign_port":"HELSINKI (HELSINGFORS)","customer":"ZYDUS LIFESCIENCES","customerCountry":"INDIA","quantity":"20.00","actualQuantity":"20","unit":"KGS","unitRateFc":"5650","totalValueFC":"114324","currency":"USD","unitRateINR":"426010","date":"24-Jul-2021","totalValueINR":"8520200","totalValueInUsd":"114324","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29335990","bill_no":"1002864","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HELSINKI (HELSINGFORS)","supplierAddress":"KOIVU-MANKKAAN TIE 6 A P.O.BOX 28,F1-02101 ESPOO , FINLAND","customerAddress":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1628793000,"product":"METHOTREXATE (BCD: LIST 3, SL NO: 29, IGST: LIST 1, SL NO: 29)","address":"PLOT NO.2, MAITHRIVIHAR, AMEERPET,","city":"HYDERABAD, AP.","supplier":"FERMION OY","supplierCountry":"FINLAND","foreign_port":"HELSINKI","customer":"EUGIA PHARMA SPECIALITIES ","customerCountry":"INDIA","quantity":"4.39","actualQuantity":"4.389","unit":"KGS","unitRateFc":"4900","totalValueFC":"25937.5","currency":"EUR","unitRateINR":"438305","date":"13-Aug-2021","totalValueINR":"1923720.65","totalValueInUsd":"25937.5","indian_port":"HYDERABAD AIR","hs_no":"29335990","bill_no":"5038604","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HELSINKI","supplierAddress":"","customerAddress":"PLOT NO.2, MAITHRIVIHAR, AMEERPET,"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1633285800,"product":"METHOTREXATE DISODIUM SALT MILLED NP, BATCH NO:2109404","address":"Block No. 193 Part 211 Part, Xcelon Industrial Park,Chakde India Weigh","city":"Bridge Rd Vasana Chacharwadi Tal Sa","supplier":"FAREVA","supplierCountry":"GERMANY","foreign_port":"NA","customer":"FTF PHARMA PRIVATE ","customerCountry":"INDIA","quantity":"0.30","actualQuantity":"0.3","unit":"KGS","unitRateFc":"5500","totalValueFC":"1948.2","currency":"EUR","unitRateINR":"486475","date":"04-Oct-2021","totalValueINR":"145942.5","totalValueInUsd":"1948.2","indian_port":"AHMEDABAD AIR","hs_no":"29335990","bill_no":"5686853","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"Block No. 193 Part 211 Part, Xcelon Industrial Park,Chakde India Weigh"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1637001000,"product":"CHEMICAL : METHOTREXATE PH EUR","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,, S.G. HIGHWAY, THALTEJ","city":"AHMEDABAD,GUJARAT","supplier":"FAREVA","supplierCountry":"GERMANY","foreign_port":"NA","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"3600","totalValueFC":"12776.5","currency":"EUR","unitRateINR":"317160","date":"16-Nov-2021","totalValueINR":"951480","totalValueInUsd":"12776.5","indian_port":"AHMEDABAD AIR","hs_no":"29335990","bill_no":"6276651","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,, S.G. HIGHWAY, THALTEJ"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1641407400,"product":"METHOTREXATE IP\/USP, BATCH NO. 2041437,M\/D 08.03.2021, E\/D 07.03.2026","address":"B-310, SOM DATT CHAMBERS, 1,,BHIKA JI CAMA PLACE,","city":"NEW DELHI,DELHI","supplier":"FERMION OY","supplierCountry":"FINLAND","foreign_port":"HELSINKI","customer":"FRESENIUS SE & CO. KGAA","customerCountry":"INDIA","quantity":"12.53","actualQuantity":"12525","unit":"GMS","unitRateFc":"3.8","totalValueFC":"56032.9","currency":"EUR","unitRateINR":"333.3","date":"06-Jan-2022","totalValueINR":"4174081.5","totalValueInUsd":"56032.9","indian_port":"DELHI AIR","hs_no":"29224290","bill_no":"6974484","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HELSINKI","supplierAddress":"","customerAddress":"B-310, SOM DATT CHAMBERS, 1,,BHIKA JI CAMA PLACE,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1645641000,"product":"METHOTREXATE DISODIUM SALT MILLED NP (LIST NO 3,SR NO.29)","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,,","city":"AHMEDABAD,GUJARAT","supplier":"EXCELLA GMBH","supplierCountry":"GERMANY","foreign_port":"D\u00bfSSELDORF","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"20.00","actualQuantity":"20","unit":"KGS","unitRateFc":"4010.8","totalValueFC":"81385.2","currency":"USD","unitRateINR":"305019","date":"24-Feb-2022","totalValueINR":"6100380","totalValueInUsd":"81385.2","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29335990","bill_no":"1000766","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"D\u00bfSSELDORF","supplierAddress":"N\/A","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1645641000,"product":"METHOTREXATE DISODIUM SALT MILLED NP (LIST NO 3,SR NO.29)","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,,","city":"AHMEDABAD,GUJARAT","supplier":"EXCELLA GMBH","supplierCountry":"GERMANY","foreign_port":"D\u00bfSSELDORF","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"151.00","actualQuantity":"151","unit":"KGS","unitRateFc":"4000.1","totalValueFC":"612830.3","currency":"USD","unitRateINR":"304211","date":"24-Feb-2022","totalValueINR":"45935861","totalValueInUsd":"612830.3","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29335990","bill_no":"1000766","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"D\u00bfSSELDORF","supplierAddress":"N\/A","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1655749800,"product":"METHOTREXATE USP\/EP\/IP\/BP","address":"NAIR BAUG, AKURLI ROAD KANDIVILI EAST Contact No: 91986928","city":"MUMBAI MAHARASHTRA","supplier":"FERMION OY","supplierCountry":"FINLAND","foreign_port":"NA","customer":"BDH INDUSTRIES LIMITED","customerCountry":"INDIA","quantity":"68.60","actualQuantity":"68.6","unit":"KGS","unitRateFc":"3200","totalValueFC":"233827.4","currency":"EUR","unitRateINR":"265920","date":"21-Jun-2022","totalValueINR":"18242112","totalValueInUsd":"233827.4","indian_port":"BOMBAY AIR","hs_no":"29335990","bill_no":"9210926","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"NAIR BAUG, AKURLI ROAD KANDIVILI EAST Contact No: 91986928"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1658341800,"product":"METHOTREXATE DISODIUM SALT MILLED NP","address":"F 2, NO.18-17, CITY HOME RESIDENCY, RD NO.3, KAMALA NAGAR, DILSUKHNAGAR","city":"HYDERABAD, AP.","supplier":"FAREVA","supplierCountry":"GERMANY","foreign_port":"NA","customer":"SP ACCURE LABS PVT. LTD","customerCountry":"INDIA","quantity":"1.50","actualQuantity":"1.5","unit":"KGS","unitRateFc":"5500","totalValueFC":"8523.2","currency":"EUR","unitRateINR":"451825","date":"21-Jul-2022","totalValueINR":"677737.5","totalValueInUsd":"8523.2","indian_port":"HYDERABAD AIR","hs_no":"29182990","bill_no":"9647696","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"F 2, NO.18-17, CITY HOME RESIDENCY, RD NO.3, KAMALA NAGAR, DILSUKHNAGAR"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1661193000,"product":"METHOTREXATE DISODIUM SALT MILLED NP (LIST NO 3,SR NO.29)(29335990)","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,,","city":"AHMEDABAD,GUJARAT","supplier":"EXCELLA GMBH","supplierCountry":"GERMANY","foreign_port":"N\/A","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"24.00","actualQuantity":"24","unit":"KGS","unitRateFc":"3599.4","totalValueFC":"87398","currency":"USD","unitRateINR":"289750.5","date":"23-Aug-2022","totalValueINR":"6954012","totalValueInUsd":"87398","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29335990","bill_no":"1003422","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"N\/A","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1662921000,"product":"METHOTREXATE DISODIUM SALT MILLED NP US (LISTNO 3,SR NO.29)","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,,","city":"AHMEDABAD,GUJARAT","supplier":"EXCELLA GMBH","supplierCountry":"GERMANY","foreign_port":"N\/A","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"130.00","actualQuantity":"130","unit":"KGS","unitRateFc":"3544.9","totalValueFC":"462614.1","currency":"USD","unitRateINR":"285187.5","date":"12-Sep-2022","totalValueINR":"37074375","totalValueInUsd":"462614.1","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29335990","bill_no":"1003750","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"N\/A","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1664735400,"product":"CHEMICAL : METHOTREXATE PH.EUR [LIST NO.03-SR NO.29]","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,, S.G. HIGHWAY, THALTEJ","city":"AHMEDABAD,GUJARAT","supplier":"FAREVA","supplierCountry":"GERMANY","foreign_port":"NA","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"3600","totalValueFC":"3535.1","currency":"EUR","unitRateINR":"290880","date":"03-Oct-2022","totalValueINR":"290880","totalValueInUsd":"3535.1","indian_port":"AHMEDABAD AIR","hs_no":"29335990","bill_no":"2714660","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,, S.G. HIGHWAY, THALTEJ"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1665945000,"product":"METHOTREXATE USP\/EP\/IP\/BP","address":"NAIR BAUG, AKURLI ROAD KANDIVILI EAST Contact No: 91986928","city":"MUMBAI MAHARASHTRA","supplier":"FERMION OY","supplierCountry":"FINLAND","foreign_port":"NA","customer":"BDH INDUSTRIES LIMITED","customerCountry":"INDIA","quantity":"70.00","actualQuantity":"70","unit":"KGS","unitRateFc":"3200","totalValueFC":"224315.2","currency":"EUR","unitRateINR":"263680","date":"17-Oct-2022","totalValueINR":"18457600","totalValueInUsd":"224315.2","indian_port":"BOMBAY AIR","hs_no":"29335990","bill_no":"2911456","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"NAIR BAUG, AKURLI ROAD KANDIVILI EAST Contact No: 91986928"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1670178600,"product":"METHOTREXATE EP\/BP\/IP\/USP\/PH.EUR.(LIST NO.03 - SR NO.29)","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,, S.G. HIGHWAY, THALTEJ","city":"AHMEDABAD,GUJARAT","supplier":"EXCELLA GMBH","supplierCountry":"GERMANY","foreign_port":"NA","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"4.00","actualQuantity":"4","unit":"KGS","unitRateFc":"3500","totalValueFC":"14636","currency":"EUR","unitRateINR":"301525","date":"05-Dec-2022","totalValueINR":"1206100","totalValueInUsd":"14636","indian_port":"AHMEDABAD AIR","hs_no":"29335990","bill_no":"3597304","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,, S.G. HIGHWAY, THALTEJ"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1677522600,"product":"158780 METHOTREXATE BATCH NO. 2113770","address":"B-310, SOM DATT CHAMBERS, 1,,BHIKA JI CAMA PLACE,","city":"NEW DELHI,DELHI","supplier":"FERMION OY","supplierCountry":"FINLAND","foreign_port":"NA","customer":"FRESENIUS SE & CO. KGAA","customerCountry":"INDIA","quantity":"6.28","actualQuantity":"6275","unit":"GMS","unitRateFc":"3.8","totalValueFC":"26056.6","currency":"EUR","unitRateINR":"343","date":"28-Feb-2023","totalValueINR":"2152011.25","totalValueInUsd":"26056.6","indian_port":"DELHI AIR","hs_no":"29224290","bill_no":"4829777","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"B-310, SOM DATT CHAMBERS, 1,,BHIKA JI CAMA PLACE,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1688581800,"product":"METHOTREXATE DISODIUM. BATCH NO. 2140274 MAT. NO. 127104","address":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR,H","city":"AHMEDABAD,GUJARAT","supplier":"FERMION OY","supplierCountry":"FINLAND","foreign_port":"HELSINKI (HELSINGFORS)","customer":"ZYDUS LIFESCIENCES LIMITED","customerCountry":"INDIA","quantity":"38.00","actualQuantity":"38","unit":"KGS","unitRateFc":"5003.1","totalValueFC":"192109.4","currency":"USD","unitRateINR":"415510.1","date":"06-Jul-2023","totalValueINR":"15789383","totalValueInUsd":"192109.4","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29335990","bill_no":"1002878","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HELSINKI (HELSINGFORS)","supplierAddress":"KOIVU - MANKKAAN TIE 6 A, P.O.BOX 28 FI - 02101 ESPOO, FI","customerAddress":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR,H"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1702060200,"product":"METHOTREXATE USP","address":"S.C.O.857, CABIN NO. 10, 2ND FLOOR,","city":"CHANDIGARH.","supplier":"HANGZHOU ZHONGBAO IMP.&EXP.CORP. ","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"VENUS REMEDIES","customerCountry":"INDIA","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"2700","totalValueFC":"273.4","currency":"USD","unitRateINR":"227610","date":"09-Dec-2023","totalValueINR":"22761","totalValueInUsd":"273.4","indian_port":"Delhi Air","hs_no":"29419090","bill_no":"9148659","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"13F\/E -8 BUILDING WESTPORT NEW TERRITORIES NO.206 ZHENHUA RD,HANGZHOU310030 Hangzhou, , CHINA CHINA","customerAddress":"S.C.O.857, CABIN NO. 10, 2ND FLOOR,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1706034600,"product":"METHOTREXATE (CAS NO.59-05-02) (LIST 3 SR NO.29; IGST LIST NO.1 SR NO.29)","address":"MUMBAI CENTRAL,","city":"MUMBAI, MAHARASHTRA.","supplier":"FAREVA","supplierCountry":"GERMANY","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"CIPLA","customerCountry":"INDIA","quantity":"80.00","actualQuantity":"80","unit":"KGS","unitRateFc":"3550","totalValueFC":"315397.2","currency":"EUR","unitRateINR":"327665","date":"24-Jan-2024","totalValueINR":"26213200","totalValueInUsd":"315397.2","indian_port":"Bombay Air","hs_no":"29335990","bill_no":"9809275","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"FRANKFURT\/MAIN INT\\'L","supplierAddress":"NUMBERGER STR.12D-90537 FEUCHTSDNF GERMANY","customerAddress":"MUMBAI CENTRAL,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1709577000,"product":"METHOTREXATE DISODIUM (CAS NO:7413-34-5)","address":"PLOT NO.2, MAITHRIVIHAR,","city":"HYDERABAD, AP.","supplier":"FERMION OY","supplierCountry":"FINLAND","foreign_port":"HELSINKI","customer":"EUGIA PHARMA SPECIALITIES ","customerCountry":"INDIA","quantity":"81.30","actualQuantity":"81.3","unit":"KGS","unitRateFc":"4990","totalValueFC":"409909.3","currency":"USD","unitRateINR":"418661","date":"05-Mar-2024","totalValueINR":"34037139.3","totalValueInUsd":"409909.3","indian_port":"Hyderabad Air","hs_no":"29335990","bill_no":"2424749","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HELSINKI","supplierAddress":"KOIVU-MANKKAAN TIE 6 A, P.O.BOX 28FI-02200 ESPOOSDNF Finland","customerAddress":"PLOT NO.2, MAITHRIVIHAR,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1710959400,"product":"METHOTREXATE USP","address":"S.C.O.857, CABIN NO. 10, 2ND FLOOR,","city":"CHANDIGARH.","supplier":"HANGZHOU ZHONGBAO IMP.&EXP.CORP. ","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"VENUS REMEDIES","customerCountry":"INDIA","quantity":"8.00","actualQuantity":"8","unit":"KGS","unitRateFc":"2700","totalValueFC":"21785.8","currency":"USD","unitRateINR":"226125","date":"21-Mar-2024","totalValueINR":"1809000","totalValueInUsd":"21785.8","indian_port":"Delhi Air","hs_no":"29419090","bill_no":"2672509","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"13F\/E -8 BUILDING WESTPORT NEW TERRITORIES NO.206 ZHENHUA RD,HANGZHOU310030 Hangzhou, , CHINA CHINA","customerAddress":"S.C.O.857, CABIN NO. 10, 2ND FLOOR,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1712341800,"product":"METHOTREXATE DISODIUM USP","address":"76, C.P.RAMASAMY ROAD,","city":"CHENNAI, TAMIL NADU","supplier":"FLAVINE","supplierCountry":"GERMANY","foreign_port":"N|RNBERG (NUREMBERG)","customer":"APEX LABORATORIES","customerCountry":"INDIA","quantity":"0.30","actualQuantity":"0.3","unit":"KGS","unitRateFc":"28333.3","totalValueFC":"8585.8","currency":"USD","unitRateINR":"2389916.7","date":"06-Apr-2024","totalValueINR":"716975","totalValueInUsd":"8585.8","indian_port":"Madras Air","hs_no":"29335990","bill_no":"2903855","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"N|RNBERG (NUREMBERG)","supplierAddress":"61 SOUTH PARAMUS ROAD SUITE 565PARAMUS NEW JERSEYSDNF US","customerAddress":"76, C.P.RAMASAMY ROAD,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1715797800,"product":"METHOTREXATE PH.EUR. (LIST NO.03 - SR NO.29)","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,,","city":"AHMEDABAD,GUJARAT","supplier":"EXCELLA GMBH","supplierCountry":"GERMANY","foreign_port":"D\u00bfSSELDORF","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"20.00","actualQuantity":"20","unit":"KGS","unitRateFc":"3775.9","totalValueFC":"76420.9","currency":"USD","unitRateINR":"318500","date":"16-May-2024","totalValueINR":"6370000","totalValueInUsd":"76420.9","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29335990","bill_no":"1001783","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"D\u00bfSSELDORF","supplierAddress":"N\/A","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1717698600,"product":"METHOTREXATE DISODIUM","address":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR,H","city":"AHMEDABAD,GUJARAT","supplier":"FERMION OY","supplierCountry":"FINLAND","foreign_port":"HELSINKI (HELSINGFORS)","customer":"ZYDUS LIFESCIENCES LIMITED","customerCountry":"INDIA","quantity":"44.00","actualQuantity":"44","unit":"KGS","unitRateFc":"4990","totalValueFC":"221718.2","currency":"USD","unitRateINR":"420657","date":"07-Jun-2024","totalValueINR":"18508908","totalValueInUsd":"221718.2","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29335990","bill_no":"1002101","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HELSINKI (HELSINGFORS)","supplierAddress":"KOIVU-MANKKAAN TIE 6 A FI-02200 ESP OO FINLAND P.O. BOX 28,02101 FI ESP OO FINLAND FINLAND","customerAddress":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR,H"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1722191400,"product":"(N.C.V.) METHOTREXATE DISODIUM (T\/L # SW\/ND\/CT-17\/2024\/000002821)","address":"48, KANDIVLI INDUSTRIAL ESTATE,","city":"MUMBAI, MAHARASHTRA.","supplier":"FERMION OY","supplierCountry":"FINLAND","foreign_port":"HELSINKI","customer":"IPCA LABORATORIES","customerCountry":"INDIA","quantity":"2.87","actualQuantity":"2.87","unit":"KGS","unitRateFc":"4600","totalValueFC":"14640.6","currency":"EUR","unitRateINR":"426420","date":"29-Jul-2024","totalValueINR":"1223825.4","totalValueInUsd":"14640.6","indian_port":"Bombay Air","hs_no":"29419090","bill_no":"4768290","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HELSINKI","supplierAddress":"KOIVU-MANKKAAN TIE 6 A, P.O.BOX 28FI-02101 ESPOO ., , FinlandSDNF Finland","customerAddress":"48, KANDIVLI INDUSTRIAL ESTATE,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1724265000,"product":"METHOTREXATE DISODIUM","address":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR","city":"AHMEDABAD\/GUJRAT","supplier":"FERMION QY","supplierCountry":"FINLAND","foreign_port":"HELSINKI (HELSINGFOR","customer":"ZYDUS LIFESCIENCES LIMITED","customerCountry":"INDIA","quantity":"20.00","actualQuantity":"20","unit":"KGS","unitRateFc":"4990","totalValueFC":"100955.9","currency":"USD","unitRateINR":"423401.5","date":"22-Aug-2024","totalValueINR":"8468030","totalValueInUsd":"100955.9","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29335990","bill_no":"5185117","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HELSINKI (HELSINGFOR","supplierAddress":"Koivu-Mankkam Tie 6A P.O.Box.28,Espoo SDNF Finland","customerAddress":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1724610600,"product":"METHOTREXATE SODIUM ( METHOTREXATE DISODIUM SALT MILLED)","address":"ALEMBIC ROAD","city":"GUJARAT","supplier":"FLAVINE","supplierCountry":"GERMANY","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"ALEMBIC PHARMACEUTICALS LIMITED","customerCountry":"INDIA","quantity":"149.78","actualQuantity":"149.78","unit":"KGS","unitRateFc":"3600","totalValueFC":"545452.9","currency":"USD","unitRateINR":"305460","date":"26-Aug-2024","totalValueINR":"45751798.8","totalValueInUsd":"545452.9","indian_port":"Bombay Air","hs_no":"29335990","bill_no":"5257156","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"FRANKFURT\/MAIN INT\\'L","supplierAddress":"61 SOUTH PARAMUS ROAD,SUITE 565 PARMUS,NEW JERSEY 07652SDNF U.S.A.","customerAddress":"ALEMBIC ROAD"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1727980200,"product":"METHOTREXATE (LIST 3 SR NO.29; IGST LIST NO.1 SR NO.29)","address":"MUMBAI CENTRAL,","city":"MUMBAI, MAHARASHTRA.","supplier":"FAREVA","supplierCountry":"GERMANY","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"CIPLA","customerCountry":"INDIA","quantity":"36.30","actualQuantity":"36300","unit":"GMS","unitRateFc":"3.4","totalValueFC":"138436.4","currency":"EUR","unitRateINR":"320.5","date":"04-Oct-2024","totalValueINR":"11632335","totalValueInUsd":"138436.4","indian_port":"Bombay Air","hs_no":"29335990","bill_no":"5954534","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"FRANKFURT\/MAIN INT\\'L","supplierAddress":"NUMBERGER STR.12 D-90537 FEUCHT SDNF GERMANY","customerAddress":"MUMBAI CENTRAL,"}]
    29-Jan-2021
    04-Oct-2024
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    FDF Dossiers

    read-more
    read-more

    01

    Orion Corporation

    Finland
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Generic

    Registration Country : Canada

    Methotrexate

    Brand Name :

    Dosage Form : TABLET

    Dosage Strength : 2.5MG

    Packaging :

    Approval Date :

    Application Number : 40233

    Regulatory Info : Generic

    Registration Country : Canada

    Fermion Orion Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Orion Corporation

    Finland
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Generic ANDA Granted, Available outside USA

    Registration Country : Canada

    Methotrexate

    Brand Name :

    Dosage Form : TABLET

    Dosage Strength : 10MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info : Generic ANDA Granted, Available outside USA

    Registration Country : Canada

    Fermion Orion Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Orion Corporation

    Finland
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Sweden

    metotrexat

    Brand Name : Methotrexate Orion

    Dosage Form : TABLETT

    Dosage Strength : 2,5 MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Sweden

    Fermion Orion Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Orion Corporation

    Finland
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Sweden

    metotrexat

    Brand Name : Methotrexate Orion

    Dosage Form : INJEKTIONSVÄTSKA, LÖSNING, FÖRFYLLD SPRUTA

    Dosage Strength : 25 MG/ML

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Sweden

    Fermion Orion Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Orion Corporation

    Finland
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Methotrexate

    Brand Name : Methotrexate Orion

    Dosage Form : Injection fluid, resolution in the finished filled syringe

    Dosage Strength : 25 mg/ml

    Packaging : Finish filled syringe

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    Fermion Orion Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Orion Corporation

    Finland
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Methotrexate

    Brand Name : Methotrexate Orion

    Dosage Form : Injection fluid, resolution in the finished filled syringe

    Dosage Strength : 25 mg/ml

    Packaging : Finish filled syringe

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    Fermion Orion Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Orion Corporation

    Finland
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Methotrexate

    Brand Name : Methotrexate Orion

    Dosage Form : Injection fluid, resolution in the finished filled syringe

    Dosage Strength : 25 mg/ml

    Packaging : Finish filled syringe

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    Fermion Orion Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Orion Corporation

    Finland
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Methotrexate

    Brand Name : Methotrexate Orion

    Dosage Form : Injection fluid, resolution in the finished filled syringe

    Dosage Strength : 25 mg/ml

    Packaging : Finish filled syringe

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    Fermion Orion Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Orion Corporation

    Finland
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Methotrexate

    Brand Name : Methotrexate Orion

    Dosage Form : Injection fluid, resolution in the finished filled syringe

    Dosage Strength : 25 mg/ml

    Packaging : Finish filled syringe

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    Fermion Orion Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Polfa Tarchomin

    Poland
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothPolfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Contact Supplier Contact Supplier
    Flag Poland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Dossier Availability: Q3 2026

    Registration Country : Poland

    Methotrexate

    Brand Name :

    Dosage Form : Solution for Injection

    Dosage Strength : 50MG/ML

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info : Dossier Availability: Q3 2026

    Registration Country : Poland

    Polfa Tarchomin

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDA Orange Book

    read-more
    read-more

    01

    STRIDES PHARMA

    India
    arrow
    CPhI India 2024
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    METHOTREXATE SODIUM

    Brand Name : METHOTREXATE SODIUM

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Approval Date : 1982-01-01

    Application Number : 8085

    RX/OTC/DISCN : DISCN

    RLD : Yes

    TE Code :

    Strides Pharma Science

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    ABIC

    Israel
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    ABIC

    Israel
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code :

    METHOTREXATE SODIUM

    Brand Name : ABITREXATE

    Dosage Form : INJECTABLE;INJECTION

    Dosage Strength : EQ 250MG BASE/VIAL

    Approval Date : 1987-07-17

    Application Number : 89356

    RX/OTC/DISCN : DISCN

    RLD : No

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    ACCORD HLTHCARE

    United Kingdom
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    ACCORD HLTHCARE

    United Kingdom
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code : AB

    METHOTREXATE SODIUM

    Brand Name : METHOTREXATE SODIUM

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 2.5MG BASE

    Approval Date : 2020-01-24

    Application Number : 213343

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    BARR

    U.S.A
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    BARR

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code : AB

    METHOTREXATE SODIUM

    Brand Name : METHOTREXATE SODIUM

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 2.5MG BASE

    Approval Date : 1990-10-15

    Application Number : 81099

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    BRISTOL MYERS SQUIBB

    U.S.A
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    BRISTOL MYERS SQUIBB

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code :

    METHOTREXATE SODIUM

    Brand Name : MEXATE-AQ PRESERVED

    Dosage Form : INJECTABLE;INJECTION

    Dosage Strength : EQ 25MG BASE/ML

    Approval Date : 1989-04-14

    Application Number : 89887

    RX/OTC/DISCN : DISCN

    RLD : No

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    DAITO

    Japan
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    DAITO

    Japan
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code : AB

    METHOTREXATE SODIUM

    Brand Name : METHOTREXATE SODIUM

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 2.5MG BASE

    Approval Date : 2023-08-07

    Application Number : 213362

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    HOSPIRA

    U.S.A
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    HOSPIRA

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    METHOTREXATE SODIUM

    Brand Name : METHOTREXATE PRESERVATIVE FREE

    Dosage Form : INJECTABLE;INJECTION

    Dosage Strength : EQ 2.5GM BASE/100ML (EQ 25MG BASE/ML)

    Approval Date : 2005-04-13

    Application Number : 11719

    RX/OTC/DISCN : DISCN

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    MEDEXUS

    Canada
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    MEDEXUS

    Canada
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    METHOTREXATE

    Brand Name : RASUVO

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 20MG/0.4ML (20MG/0.4ML)

    Approval Date : 2014-07-10

    Application Number : 205776

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    QUAD PHARMS

    South Africa
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    QUAD PHARMS

    South Africa
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag South Africa
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD :

    TE Code :

    METHOTREXATE SODIUM

    Brand Name : METHOTREXATE SODIUM

    Dosage Form : Injectable; Injection

    Dosage Strength : EQ 25MG BASE/ML

    Approval Date :

    Application Number : 89309

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    MYLAN

    U.S.A
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    MYLAN

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code : AB

    METHOTREXATE SODIUM

    Brand Name : METHOTREXATE SODIUM

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 2.5MG BASE

    Approval Date : 1992-05-15

    Application Number : 81235

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Listed Dossiers

    read-more
    read-more

    01

    Polfa Tarchomin

    Poland
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothPolfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Contact Supplier Contact Supplier
    Flag Poland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Dossier Availability: Q3 2026

    Registration Country : Poland

    Methotrexate

    Brand Name :

    Dosage Form : Solution for Injection

    Dosage Strength : 50MG/ML

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info : Dossier Availability: Q3 2026

    Registration Country : Poland

    Polfa Tarchomin

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    01

    Polfa Tarchomin

    Poland
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothPolfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Contact Supplier Contact Supplier
    Flag Poland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging :

    Regulatory Info : Dossier Availability: Q3 2026

    Methotrexate

    Dosage : Solution for Injection

    Dosage Strength : 50MG/ML

    Brand Name :

    Approval Date :

    Application Number :

    Registration Country : Poland

    Polfa Tarchomin

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    NanoAlvand

    Iran
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Contact Supplier Contact Supplier
    Flag Iran
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Iran

    Methotrexate

    Brand Name : Reximed

    Dosage Form : Vial

    Dosage Strength : 50MG/2ML

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Iran

    NanoAlvand

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    NanoAlvand

    Iran
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Contact Supplier Contact Supplier
    Flag Iran
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging :

    Regulatory Info :

    Methotrexate

    Dosage : Vial

    Dosage Strength : 50MG/2ML

    Brand Name : Reximed

    Approval Date :

    Application Number :

    Registration Country : Iran

    NanoAlvand

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    NanoAlvand

    Iran
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Contact Supplier Contact Supplier
    Flag Iran
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Iran

    Methotrexate

    Brand Name : Reximed

    Dosage Form : Vial

    Dosage Strength : 1000MG/10ML

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Iran

    NanoAlvand

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    NanoAlvand

    Iran
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Contact Supplier Contact Supplier
    Flag Iran
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging :

    Regulatory Info :

    Methotrexate

    Dosage : Vial

    Dosage Strength : 1000MG/10ML

    Brand Name : Reximed

    Approval Date :

    Application Number :

    Registration Country : Iran

    NanoAlvand

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    NanoAlvand

    Iran
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Contact Supplier Contact Supplier
    Flag Iran
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Iran

    Methotrexate

    Brand Name : Reximed

    Dosage Form : Vial

    Dosage Strength : 50MG/2ML

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Iran

    NanoAlvand

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    NanoAlvand

    Iran
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Contact Supplier Contact Supplier
    Flag Iran
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging :

    Regulatory Info :

    Methotrexate

    Dosage : Vial

    Dosage Strength : 50MG/2ML

    Brand Name : Reximed

    Approval Date :

    Application Number :

    Registration Country : Iran

    NanoAlvand

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    NanoAlvand

    Iran
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Contact Supplier Contact Supplier
    Flag Iran
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Iran

    Methotrexate

    Brand Name : Reximed

    Dosage Form : Vial

    Dosage Strength : 1000MG/10ML

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Iran

    NanoAlvand

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    NanoAlvand

    Iran
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Contact Supplier Contact Supplier
    Flag Iran
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging :

    Regulatory Info :

    Methotrexate

    Dosage : Vial

    Dosage Strength : 1000MG/10ML

    Brand Name : Reximed

    Approval Date :

    Application Number :

    Registration Country : Iran

    NanoAlvand

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    NanoAlvand

    Iran
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Contact Supplier Contact Supplier
    Flag Iran
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Iran

    Methotrexate

    Brand Name : Trexoma

    Dosage Form : Prefilled Syringe

    Dosage Strength : 7.5MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Iran

    NanoAlvand

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    NanoAlvand

    Iran
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Contact Supplier Contact Supplier
    Flag Iran
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging :

    Regulatory Info :

    Methotrexate

    Dosage : Prefilled Syringe

    Dosage Strength : 7.5MG

    Brand Name : Trexoma

    Approval Date :

    Application Number :

    Registration Country : Iran

    NanoAlvand

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    NanoAlvand

    Iran
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Contact Supplier Contact Supplier
    Flag Iran
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Iran

    Methotrexate

    Brand Name : Trexoma

    Dosage Form : Prefilled Syringe

    Dosage Strength : 10MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Iran

    NanoAlvand

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    NanoAlvand

    Iran
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Contact Supplier Contact Supplier
    Flag Iran
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging :

    Regulatory Info :

    Methotrexate

    Dosage : Prefilled Syringe

    Dosage Strength : 10MG

    Brand Name : Trexoma

    Approval Date :

    Application Number :

    Registration Country : Iran

    NanoAlvand

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    NanoAlvand

    Iran
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Contact Supplier Contact Supplier
    Flag Iran
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Iran

    Methotrexate

    Brand Name : Trexoma

    Dosage Form : Prefilled Syringe

    Dosage Strength : 15MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Iran

    NanoAlvand

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    NanoAlvand

    Iran
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Contact Supplier Contact Supplier
    Flag Iran
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging :

    Regulatory Info :

    Methotrexate

    Dosage : Prefilled Syringe

    Dosage Strength : 15MG

    Brand Name : Trexoma

    Approval Date :

    Application Number :

    Registration Country : Iran

    NanoAlvand

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    NanoAlvand

    Iran
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Contact Supplier Contact Supplier
    Flag Iran
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Iran

    Methotrexate

    Brand Name : Trexoma

    Dosage Form : Prefilled Syringe

    Dosage Strength : 20MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Iran

    NanoAlvand

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    NanoAlvand

    Iran
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Contact Supplier Contact Supplier
    Flag Iran
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging :

    Regulatory Info :

    Methotrexate

    Dosage : Prefilled Syringe

    Dosage Strength : 20MG

    Brand Name : Trexoma

    Approval Date :

    Application Number :

    Registration Country : Iran

    NanoAlvand

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    NanoAlvand

    Iran
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Contact Supplier Contact Supplier
    Flag Iran
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Iran

    Methotrexate

    Brand Name : Trexoma

    Dosage Form : Prefilled Syringe

    Dosage Strength : 25MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Iran

    NanoAlvand

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    NanoAlvand

    Iran
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Contact Supplier Contact Supplier
    Flag Iran
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging :

    Regulatory Info :

    Methotrexate

    Dosage : Prefilled Syringe

    Dosage Strength : 25MG

    Brand Name : Trexoma

    Approval Date :

    Application Number :

    Registration Country : Iran

    NanoAlvand

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    DRUG PRODUCT COMPOSITIONS

    Do you need Business Intel? Ask us

    DOSAGE - INJECTABLE;INJECTION - EQ 100MG BASE...DOSAGE - INJECTABLE;INJECTION - EQ 100MG BASE/VIAL

    USFDA APPLICATION NUMBER - 11719

    read-more

    DOSAGE - INJECTABLE;INJECTION - EQ 1GM BASE/V...DOSAGE - INJECTABLE;INJECTION - EQ 1GM BASE/VIAL

    USFDA APPLICATION NUMBER - 11719

    read-more

    DOSAGE - INJECTABLE;INJECTION - EQ 1GM BASE/4...DOSAGE - INJECTABLE;INJECTION - EQ 1GM BASE/40ML (EQ 25MG BASE/ML)

    USFDA APPLICATION NUMBER - 11719

    read-more

    DOSAGE - INJECTABLE;INJECTION - EQ 2.5GM BASE...DOSAGE - INJECTABLE;INJECTION - EQ 2.5GM BASE/100ML (EQ 25MG BASE/ML)

    USFDA APPLICATION NUMBER - 11719

    read-more

    DOSAGE - INJECTABLE;INJECTION - EQ 2.5MG BASE...DOSAGE - INJECTABLE;INJECTION - EQ 2.5MG BASE/ML

    USFDA APPLICATION NUMBER - 11719

    read-more

    DOSAGE - INJECTABLE;INJECTION - EQ 20MG BASE/...DOSAGE - INJECTABLE;INJECTION - EQ 20MG BASE/VIAL

    USFDA APPLICATION NUMBER - 11719

    read-more

    DOSAGE - INJECTABLE;INJECTION - EQ 20MG BASE/...DOSAGE - INJECTABLE;INJECTION - EQ 20MG BASE/2ML (EQ 10MG BASE/ML)

    USFDA APPLICATION NUMBER - 11719

    read-more

    DOSAGE - INJECTABLE;INJECTION - EQ 25MG BASE/...DOSAGE - INJECTABLE;INJECTION - EQ 25MG BASE/ML

    USFDA APPLICATION NUMBER - 11719

    read-more

    DOSAGE - INJECTABLE;INJECTION - EQ 500MG BASE...DOSAGE - INJECTABLE;INJECTION - EQ 500MG BASE/20ML (EQ 25MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    USFDA APPLICATION NUMBER - 11719

    read-more

    DOSAGE - INJECTABLE;INJECTION - EQ 50MG BASE/...DOSAGE - INJECTABLE;INJECTION - EQ 50MG BASE/VIAL

    USFDA APPLICATION NUMBER - 11719

    read-more

    DOSAGE - INJECTABLE;INJECTION - EQ 50MG BASE/...DOSAGE - INJECTABLE;INJECTION - EQ 50MG BASE/2ML (EQ 25MG BASE/ML)

    USFDA APPLICATION NUMBER - 11719

    read-more

    DOSAGE - SOLUTION;SUBCUTANEOUS - 10MG/0.4ML (...DOSAGE - SOLUTION;SUBCUTANEOUS - 10MG/0.4ML (10MG/0.4ML)

    USFDA APPLICATION NUMBER - 210737

    read-more

    DOSAGE - SOLUTION;SUBCUTANEOUS - 12.5MG/0.5ML...DOSAGE - SOLUTION;SUBCUTANEOUS - 12.5MG/0.5ML (12.5MG/0.5ML)

    USFDA APPLICATION NUMBER - 210737

    read-more

    DOSAGE - SOLUTION;SUBCUTANEOUS - 15MG/0.6ML (...DOSAGE - SOLUTION;SUBCUTANEOUS - 15MG/0.6ML (15MG/0.6ML)

    USFDA APPLICATION NUMBER - 210737

    read-more

    DOSAGE - SOLUTION;SUBCUTANEOUS - 17.5MG/0.7ML...DOSAGE - SOLUTION;SUBCUTANEOUS - 17.5MG/0.7ML (17.5MG/0.7ML)

    USFDA APPLICATION NUMBER - 210737

    read-more

    DOSAGE - SOLUTION;SUBCUTANEOUS - 20MG/0.8ML (...DOSAGE - SOLUTION;SUBCUTANEOUS - 20MG/0.8ML (20MG/0.8ML)

    USFDA APPLICATION NUMBER - 210737

    read-more

    DOSAGE - SOLUTION;SUBCUTANEOUS - 22.5MG/ML (2...DOSAGE - SOLUTION;SUBCUTANEOUS - 22.5MG/ML (22.5MG/ML)

    USFDA APPLICATION NUMBER - 210737

    read-more

    DOSAGE - SOLUTION;SUBCUTANEOUS - 25MG/1ML (25...DOSAGE - SOLUTION;SUBCUTANEOUS - 25MG/1ML (25MG/1ML)

    USFDA APPLICATION NUMBER - 210737

    read-more

    DOSAGE - SOLUTION;SUBCUTANEOUS - 7.5MG/0.3ML ...DOSAGE - SOLUTION;SUBCUTANEOUS - 7.5MG/0.3ML (7.5MG/0.3ML)

    USFDA APPLICATION NUMBER - 210737

    read-more

    DOSAGE - TABLET;ORAL - EQ 2.5MG BASE **Federa...DOSAGE - TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    USFDA APPLICATION NUMBER - 8085

    read-more

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Fillers, Diluents & Binders

    read-more
    read-more

    Coating Systems & Additives

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Granulation

    read-more
    read-more

    Solubilizers

    read-more
    read-more

    Topical

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    Empty Capsules

    read-more
    read-more

    API Stability Enhancers

    read-more
    read-more

    Coloring Agents

    read-more
    read-more

    Rheology Modifiers

    read-more
    read-more

    Vegetarian Capsules

    read-more
    read-more

    Surfactant & Foaming Agents

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    DATA COMPILATION #PharmaFlow

    read-more
    read-more

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    US Patents

    read-more
    read-more

    01

    AZURITY

    METHOTREXATE SODIUM

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    AZURITY

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Patent Expiration Date : 2033-01-02

    METHOTREXATE SODIUM

    US Patent Number : 11969503

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 208400

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2033-01-02

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    AZURITY

    METHOTREXATE SODIUM

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    AZURITY

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Patent Expiration Date : 2033-01-02

    METHOTREXATE SODIUM

    US Patent Number : 9855215

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 208400

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2033-01-02

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    MEDEXUS

    METHOTREXATE

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    MEDEXUS

    Canada
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Patent Expiration Date : 2029-06-01

    METHOTREXATE

    US Patent Number : 8664231

    Drug Substance Claim :

    Drug Product Claim :

    Application Number : 205776

    Patent Use Code : U-1442

    Delist Requested :

    Patent Use Description : SUBCUTANEOUS INJECTION...

    Patent Expiration Date : 2029-06-01

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    SHORLA

    METHOTREXATE

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    SHORLA

    Ireland
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Patent Expiration Date : 2034-10-29

    METHOTREXATE

    US Patent Number : 11771701

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 212479

    Patent Use Code : U-3701

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2034-10-29

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    OTTER PHARMS

    METHOTREXATE

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    OTTER PHARMS

    Country
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Patent Expiration Date : 2026-01-24

    METHOTREXATE

    US Patent Number : 8562564

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 204824

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2026-01-24

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    OTTER PHARMS

    METHOTREXATE

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    OTTER PHARMS

    Country
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Patent Expiration Date : 2029-03-10

    METHOTREXATE

    US Patent Number : 11684723

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 204824

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2029-03-10

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    OTTER PHARMS

    METHOTREXATE

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    OTTER PHARMS

    Country
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Patent Expiration Date : 2029-03-10

    METHOTREXATE

    US Patent Number : 10709844

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 204824

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2029-03-10

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    OTTER PHARMS

    METHOTREXATE

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    OTTER PHARMS

    Country
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Patent Expiration Date : 2029-03-10

    METHOTREXATE

    US Patent Number : 11684723

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 204824

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2029-03-10

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    OTTER PHARMS

    METHOTREXATE

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    OTTER PHARMS

    Country
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Patent Expiration Date : 2030-03-19

    METHOTREXATE

    US Patent Number : 8579865

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 204824

    Patent Use Code : U-1442

    Delist Requested :

    Patent Use Description : SUBCUTANEOUS INJECTION...

    Patent Expiration Date : 2030-03-19

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    OTTER PHARMS

    METHOTREXATE

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    OTTER PHARMS

    Country
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Patent Expiration Date : 2026-01-24

    METHOTREXATE

    US Patent Number : 11446441

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 204824

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2026-01-24

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    US Exclusivities

    read-more
    read-more

    AZURITY

    Contact Supplier
      • fda
      • EDQM
      • WHO-GMP
      Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      METHOTREXATE SODIUM

      Portfolio PDF

      Product Web Link

      Virtual Booth

      Digital Content

      Website

      Corporate PDF

      ODE-137
      2024-04-25
      208400
      1
      blank

      01

      AZURITY

      METHOTREXATE SODIUM

      arrow
      Pharmtech & Ingredients
      Not Confirmed

      AZURITY

      U.S.A
      arrow
      Pharmtech & Ingredients
      Not Confirmed

      METHOTREXATE SODIUM

      Exclusivity Code : ODE-137

      Exclusivity Expiration Date : 2024-04-25

      Application Number : 208400

      Product Number : 1

      Exclusivity Details :

      blank

      Portfolio PDF

      Product Web Link

      Virtual Booth

      Digital Content

      Website

      Corporate PDF

      AZURITY

      Contact Supplier
        • fda
        • EDQM
        • WHO-GMP
        Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
        Post an Enquiry Post an Enquiry
        Flag U.S.A
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        METHOTREXATE SODIUM

        Portfolio PDF

        Product Web Link

        Virtual Booth

        Digital Content

        Website

        Corporate PDF

        ODE-138
        2024-04-25
        208400
        1
        blank

        02

        AZURITY

        METHOTREXATE SODIUM

        arrow
        Pharmtech & Ingredients
        Not Confirmed

        AZURITY

        U.S.A
        arrow
        Pharmtech & Ingredients
        Not Confirmed

        METHOTREXATE SODIUM

        Exclusivity Code : ODE-138

        Exclusivity Expiration Date : 2024-04-25

        Application Number : 208400

        Product Number : 1

        Exclusivity Details :

        blank

        Portfolio PDF

        Product Web Link

        Virtual Booth

        Digital Content

        Website

        Corporate PDF

        Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

        REF. STANDARDS & IMPURITIES

        Upload your portfolio for free, ask us

        USP

        read-more
        read-more

        ABOUT THIS PAGE

        Ask Us for Pharmaceutical Supplier and Partner
        Ask Us, Find A Supplier / Partner
        No Commissions, No Strings Attached, Get Connected for FREE

        What are you looking for?

        How can we help you?

        The request can't be empty

        Please read our Privacy Policy carefully

        You must agree to the privacy policy

        The name can't be empty
        The company can't be empty.
        The email can't be empty Please enter a valid email.
        The mobile can't be empty

        Market Place

        Market Place

        PharmaCompass

        Home

        Market Place

        Menu

        Post Enquiry

        Post Enquiry

        Market Place

        Market Place

        Search